BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35409355)

  • 1. Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.
    Iannantuono GM; Riondino S; Sganga S; Roselli M; Torino F
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409355
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
    Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.
    Yang J; Dong L; Du H; Li XB; Liang YX; Liu GR
    Diagn Pathol; 2019 Oct; 14(1):112. PubMed ID: 31627758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
    Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
    Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
    Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
    Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of anaplastic lymphoma kinase fusion in clear cell renal carcinoma (ALK-tRCC): a precision oncology medicine case report.
    Varchetta V; Campanella C; Rossi M; Verzaro R; Vitale M; Soda G; Mancuso A
    Recenti Prog Med; 2021 Jan; 112(1):14e-15e. PubMed ID: 33512368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.
    Yu W; Wang Y; Jiang Y; Zhang W; Li Y
    Histopathology; 2017 Jul; 71(1):53-62. PubMed ID: 28199742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK-rearranged renal cell carcinomas in Polish population.
    Gorczynski A; Czapiewski P; Korwat A; Budynko L; Prelowska M; Okon K; Biernat W
    Pathol Res Pract; 2019 Dec; 215(12):152669. PubMed ID: 31677810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
    Doğan K; Onder E
    Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Renal Cell Carcinoma Harboring
    Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
    Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.
    Wang XT; Fang R; Ye SB; Zhang RS; Li R; Wang X; Ji RH; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
    Pathol Res Pract; 2019 Nov; 215(11):152651. PubMed ID: 31563285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.
    Bodokh Y; Ambrosetti D; Kubiniek V; Tibi B; Durand M; Amiel J; Pertuit M; Barlier A; Pedeutour F
    Cancer Genet; 2018 Feb; 221():31-37. PubMed ID: 29405994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
    Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G
    Eur J Cancer; 2021 Nov; 157():198-213. PubMed ID: 34536944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
    Hang JF; Chung HJ; Pan CC
    Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report.
    Kai K; Tobu S; Kido S; Mikami S; Takeuchi K; Dobashi A; Togashi Y; Noguchi M; Aishima S
    Diagn Pathol; 2022 Jun; 17(1):52. PubMed ID: 35718773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC).
    Golding B; Luu A; Jones R; Viloria-Petit AM
    Mol Cancer; 2018 Feb; 17(1):52. PubMed ID: 29455675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.
    Chen W; Li W; Bai B; Wei H
    Oncol Rep; 2020 Mar; 43(3):817-826. PubMed ID: 32020234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation carcinomas of the kidney.
    Argani P
    Genes Chromosomes Cancer; 2022 May; 61(5):219-227. PubMed ID: 34704642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.
    Sugawara E; Togashi Y; Kuroda N; Sakata S; Hatano S; Asaka R; Yuasa T; Yonese J; Kitagawa M; Mano H; Ishikawa Y; Takeuchi K
    Cancer; 2012 Sep; 118(18):4427-36. PubMed ID: 22252991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
    Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.